Member Info for Luckenbach

Why not to make plans together with Partner candidates if any?

Would ’nt it be nice to have a druc that could make it possible to experience an extra day, an extra day.. Would’nt it . To experience 31st of Aprill I have no recommendation and guarantee but maybe Lucie in the sky could help in this.

…than 31st of Aprill

Would be nice but impossible. Much more possible sooner or later.

Maybe JPM is for BPs. Hopefully the « Trojans horse « is in.

Cairn could be CFO’s choice as a partner as it probably also was it in the earlier days before the eras of the two other CFOs in between?

Table is clear for serious offers and negotiations without any old bindings and twists in that concern.

It’s hard to imagine until…Once upon a time, I have heard, in Southampton it was building up a queue in front of the local Porsche dealer and they were running out of booklets and brochures but suddenly it all vanished over a night and the dealer through he must have been dreaming.

Anyway we all know why it is so important to succeed in this.

I guess they just wanted to go with minimal risk and accepted the results as long as they were able to solve the financing. I think if they had gone abroad to new investors, the rise should have been bigger thus bigger dilution and higher costs of arranging .

Congratulations, clearly wanted to have mainly domestic owners. Maybe not yet time for testing JPM contacts and why to bother them with such small sums.

This could be a nice opportunity for somebody to step in cheaply with some 5million shares, even with a bit higher price than the today’s closing price?

…if not criminal but should be restricted.

The silent weeks are about here. If there was any discussion going on about share issue with deep pockets, it would be criminal to use the information in share trading. Let’s see if the sp sliding stops here.

The "silent period," also known as the "quiet period," is a timeframe that typically starts a few weeks before a company is scheduled to release its annual (or quarterly) financial report. During this period, company executives and insiders are restricted from discussing or disclosing any material financial information that hasn't been publicly announced. This helps prevent any potential conflicts of interest or insider trading that could unfairly influence the company's stock price.

Cov, not sure if you can find us here after few months, various reasons can lead to that. You’ll find more about alternative pathways if you visit the other interferon-b1a company chat elsewhere on the lse.aim cb. Hurry up, I guess not much time left there.

From now on, at least, nobody in this field can say you haven’t heard about Bex and Faron. That’s because Dr Amer Zeidan mentioned Bex and Faron in the post ASH webinar.

He also said that MDS patients should get in to bone marrow transplantations as early as possible. And this should override the needs of clinical programs etc. That means with Bex you’re achieving something very significant - a life.

What happens is a bidding war. If not it’s poorly managed. IMO

Westernglory, have I missed a joke or why are you talking about somebody called Julho? If it’s a joke, ok. Otherwise your observations not very accurate at all what ever you say. Don’t take this bad and enjoy your morning glories. We all are expecting it to happen every/any morning soon.

Not so ethical question but what would happen to the expected sales figures if patients were allowed to bone marrow transplantation as early as possible.

Imagine if the first line MDS patient data wouldn’t meet the expectations, then the only way to continue was to have strong r/r data soonest.

Leaving the option open to continue to treat r/r MDS patients in the current protocol, to strengthen the data set further.

Could it be that there are so many patients in desperate situations waiting for to get in the program. Don’t know if it were ok to get funded for extra patients by some patient associations.

Maybe Faron needs more patients to collect the data if « too many » patients are already allowed to get transplants.

Well it may not resonate with your own investment philosophy but…don’t take the following too seriously.

Like said WB invests (through Berkshire Hathaway)in well established companies like CocaCola, Heinz, Apple etc. and they have seen the future of major companies better than many others. They are not everywhere and lately maybe missed some opportunities. Sometimes they have seen the potential through acquisitions.

Berkshire Hathaway made significant investments in pharmaceutical companies during Covid (like AbbVie, BMS, Merck, Pfizer) but they have already scaled down and maybe still having some Merck, while not being focused much on pharmaceutical companies anymore currently ?

You never know if they patiently see, better than others, that somewhere there is a tiny little thing that could be a game changer for Merck? Should somebody go and ask? In case they still have Merck in their portfolio, something is going to happen. And if not having Merck anymore then sorry for the false alert.

Have a nice weekend

Yes, WB is engaged with well established enterprises.